IMPORTANT SAFETY INFORMATIONPRESCRIBING INFORMATION

FOLOTYN is indicated for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (R/R PTCL). This indication is based on overall response rate. Clinical benefit such as improvement in progression-free survival or overall survival has not been demonstrated.

Spectrum is committed to helping you and your patients access FOLOTYN

Spectrum Therapy Access Resources (STAR®)

Spectrum Therapy Access Resources

STAR is a reimbursement support, co-pay assistance, and patient assistance program designed to help patients and health care professionals gain appropriate access to certain Spectrum products.

Reimbursement Support Services

  • Verification of patient-specific insurance benefits
  • Presubmission claims review and support
  • Prior authorization assistance
  • Coding and billing guidance
  • Payer research
  • Denied and underpaid claims assistance
  • Alternate funding research

Co-Pay Assistance Services

For eligible patients with commercial healthcare insurance, STAR will cover 100% of the co-insurance/cost share for the fi rst FOLOTYN date of service.

  • The co-pay program provides up to $10,000 per calendar year to assist with patient cost share (co-pay, co-insurance, or FOLOTYN deductible expenses). The patient is responsible for any out of pocket costs above this amount.
  • STAR provides co-pay assistance to privately-insured patients who meet program eligibility criteria. Government-insured patients (i.e., Medicare, Medicaid, etc.) are not eligible for the STAR co-pay assistance programs*.

Patient Assistance Program

  • The STAR program includes a patient assistance program (PAP) that provides FOLOTYN free of charge to enrolled patients who meet the income, insurance, and citizenship/residency eligibility criteria.
  • If approved, the STAR distributor will ship patient-labeled product to the prescribing physician for future outpatient therapy
  • The STAR PAP does not replace product administered prior to the patient’s PAP approval date.

*Only valid in the United States and Puerto Rico; this offer is void where prohibited by law, taxed, or restricted.

Call 1-888-53-STAR-7 OR 1-888-537-8277

Spectrum Pharmaceuticals, Inc.® does not guarantee coverage and/or reimbursement for its products. Coverage, coding, and reimbursement policies vary significantly by payer, patient, and setting of care. Actual coverage and reimbursement decisions are made by individual payers following the receipt of claims. Healthcare professionals should always verify coverage, coding, and reimbursement guidelines on a payer and patient-specific basis. Spectrum Pharmaceuticals, Inc. reserves the right to change eligibility guidelines, terminate, or modify the STAR program at any time for any reason.